Model to evaluate the cost-effectiveness of different antibiotics in the management of acute bacterial exacerbations of chronic bronchitis in Germany

References

• Bariffi F, Sanduzzi A, Ponticiello A. Epidemiology of lower respiratory tract infections (review). Journal of Chemotherapy 1995; 7(4): 263–76
   Google Scholar
• Skudlarska BA, Scott GC. The role of antibiotics in the management of acute exacerbations of chronic bronchitis (answers to commonly asked questions). Missouri Medicine 1992; 89(5): 289–93
   Google Scholar
• Murphy TF, Sethi S. State-of-the-art bacterial infection in chronic obstructive disease. Am Rev Respir Dis 1992: 146(4): 1067–83
   Google Scholar
• Kanner RE, Renzetti AD Jr, Klauber MR. Variables associated with changes in spirometry in patients with obstructive lung diseases. The American Journal of Medicine 1979; 67(1): 44–50
   Google Scholar
• Wilson R. The pathogenesis and management of bronchial infections: the vicious circle of respiratory decline. Rev Contemp Pharmacother 1992; 3: 103–12
   Google Scholar
• Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. New England Journal of Medicine 1969; 280(8): 379–404
   Google Scholar
• Gleckman R. “Infectious bronchitis” in Rakel R E (editor) Conn’s Current Therapy. W B Saunders, Philadelphia, 1995: 174–6
   Google Scholar
• Brambilla C, Kastanakis S, Knight S et al. Cefuroxime and cefuroxime axetil versus amoxycillin plus clavulanic acid in the treatment of lower respiratory tract infections. Eur J Clin Microbiol Infect Dis 1992; 11(2): 118–24
   Google Scholar
• Chow AW, Hall CB, Klein JO. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Clin Infect Dis 1992; 15(suppl 1): S62-S88
   Google Scholar
• Verbist L. What and where are the pathogens? Clinical significance of antibiotic tissue concentrations. Research and Clinical Forums 1990; 12(4): 9–14
   Google Scholar
• Burge PS. Occupation and chronic obstructive pulmonary disease (COPD). European Respiratory Journal 1994; 7: 1032–4
   PubMed Web of Science ®Google Scholar
• Matsuse T, Hayashi S, Kuwano K et al. Latent adenoviral infection in the pathogenesis of chronic airways obstruction. Am Rev Respir Dis 1992; 146: 177–84
   PubMed Web of Science ®Google Scholar
• Xu X, Christiani DC, Dockery DW et al. Exposure-response relationships between occupational exposures and chronic illness: a community-based study. Am Rev Respir Dis 1992; 146: 413–8
   PubMed Web of Science ®Google Scholar
• US Bureau of the Census. Statistical Abstract of the United States, 14/e. Washington DC: US Bureau of the Census, 1994
   Google Scholar
• Woolcock AJ. Epidemiology of chronic airways disease. Chest 1989; 6(suppl 3): 302S-306S
   Google Scholar
• Garibaldi RA. Epidemiology of community acquired respiratory tract infections in adults: incidence, etiology and impact. American Journal of Medicine 1995; 78(suppl 6B): 32–7
   PubMedGoogle Scholar
• Verheij TJM, Kaptein AA, Mulder JD. Acute bronchitis: etiology, symptoms and treatment. Journal of Family Practice 1989; 6:66-9
   Google Scholar
• Higgins MW, Keller JB, Metzner HL. Smoking, socioeconomic status and chronic respiratory disease. Am Rev Respir Dis 1971; 116: 403–10
   Google Scholar
• Morrell DC. Expressions of morbidity in general practice. British Medical Journal 1971; 2: 454–8
   PubMedGoogle Scholar
• Turner-Warwick M, Hodson ME, Corrin B et al. Clinical Atlas of Respiratory Diseases. London: Gower Medical Publishing, 1990
   Google Scholar
• Intercontinental Medical Statistics (IMS), Ruislip, Middlesex: BPI/MDI, Sept 1993
   Google Scholar
• Guest JF, Morris A. Community- acquired lower respiratory tract infections: the annual cost to the National Health Service. British Journal of Medical Economics 1996; 10(3): 263–73.
   Google Scholar
• Konietzko N, Fabel H (eds). German Whitebook Pneumology Thieme: Stuttgart, New York, 1996
   Google Scholar
• Huchon GJ, Gialdroni-Grassi G, Leophonte P et al. Initial antibiotic therapy for lower respiratory tract infection in the community: a European survey. European Respiratory Journal 1996; 9:1590-5
   Google Scholar
• Saint S, Bent S, Vittinghof E et al. Antibiotics in chronic obstructive pulmonary disease exacerbations: a meta- analysis. Journal of the American Medical Association 1995; 273: 957–60
   PubMed Web of Science ®Google Scholar
• Grob PR. Antibiotic prescribing practices and patient compliance in the community. Scandinavian Journal of Infectious Diseases 1992; 83: 7–14
   Google Scholar
• Ballow CH. Cost considerations in oral antibiotic therapy. Advances in Therapy 1995; 12(4): 199–206
   Google Scholar
• Backhouse R, Shakespeare A, Hutton J. Economic evaluation of alternative antibiotic regimens in the management of acute exacerbations of chronic bronchitis. British Journal of Medical Economics 1995; 8: 11–25
   Google Scholar
• Fraschini F. Clinical efficacy and tolerance of two new macrolides, clarithromycin and josamycin, in the treatment of patients with acute exacerbations of chronic bronchitis. Journal of International Medical Research 1990; 18(2): 171–6
   PubMed Web of Science ®Google Scholar
• Punakivi L, Keistinen T, Backman R et al. Oral ofloxacin once daily and doxycycline in the treatment of acute exacerbations of chronic bronchitis. Scandinavian Journal of Infectious Diseases 1990; 68(suppl): 41–5
   Google Scholar
• Rademaker CM, Sips AP, Beumer HM et al. A double-blind comparison of low dose ofloxacin and amoxycillin/clavulanic acid in acute exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy 1990; 26(suppl D): 75–81
   PubMedGoogle Scholar
• Aldons PM. A comparison of clarithromycin with ampicillin in the treatment of outpatients with acute bacterial exacerbation of chronic bronchitis. Journal of Antimicrobial Chemotherapy 1991; 27(suppl A): 101–8
   PubMedGoogle Scholar
• Kleckow M. Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin. Fortschritte der Medizin 1991; 109(22): 450–4
   Google Scholar
• De Vleiger A, Druart M, Puttemans M. Roxithromycin versus doxycycline in the treatment of acute exacerbations of chronic bronchitis. Diagnostic Microbiology & Infectious Disease 1992; 15(suppl 4): 123S-127S
   Google Scholar
• Gotfried MH, Ellison WT. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis. The American Journal of Medicine 1992; 92(suppl 4A): 108S-113S
   Google Scholar
• Grassi C, Albera C, Pozzi E. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study. American Journal of Medicine 1992; 92(suppl 4A): 103S-107S
   Google Scholar
• Guay DPR, Craft JC. Comparative safety and efficacy of clarithromycin and ampicillin in the treatment of out-patients with acute bacterial exacerbation of chronic bronchitis. Journal of Internal Medicine 1992; 231: 295–301
   PubMedGoogle Scholar
• Legnani D, Lombardo VM, Negretto G G et al. Comparative clinical and microbiological study of amoxycillin- clavulanic acid and ciprofloxacin in acute purulent exacerbations of chronic bronchitis. Journal of Hospital Infection 1992; 22(suppl A): 69–74
   PubMedGoogle Scholar
• Zeckel ML. Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: results of US and European comparative trials. American Journal of Medicine 1992; 92(suppl 6A): 58S-64S
   Google Scholar
• Chodosh S. Treatment of acute exacerbations of chronic bronchitis: state of art. American Journal of Medicine, 1993; 94(suppl 3A): 87S-92S
   Google Scholar
• Chodosh S. Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis. American Journal of Medicine, 1993; 94(suppl 3A): 131S- 135S
   PubMedGoogle Scholar
• Gaillat J. A multicenter study comparing the safety and efficacy of dirothromycin with erythromycin in the treatment of bronchitis. Journal of Antimicrobial Chemotherapy 1993; 31(suppl C): 139–51
   PubMedGoogle Scholar
• Klietmann W, Cesana M, Rondel RK et al. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis. Antimicrobial Agents and Chemotherapy 1993; 37(11): 2298–306
   Google Scholar
• Ulmer W. Fleroxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis. The American Journal of Medicine 1993; 94(suppl 3A): 136S-141S
   PubMedGoogle Scholar
• Ball P. Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections. Eur J Clin Microbiol Infect Dis 1994; 13(10): 851–6
   Google Scholar
• Janknegt R. Fluoroquinolones: use of clinical data to aid formulary by the system of objective judgement analysis (SOJA) method. Pharma Econ 1994; 6(1): 15–33
   Google Scholar
• Verghese A, Ismail HM. Acute exacerbations of chronic bronchitis. Chronic Bronchitis 1994; 96(8): 75–89
   Google Scholar
• Beghi G, Berni F, Carratu L et al. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis. Journal of Chemotherapy 1995; 7(2): 146–52
   Google Scholar
• Cazzola M, Vinciguerra A, Beghi GF et al. Comparative evaluation of the clinical and microbiological efficacy of co- amoxiclav vs cefixime or ciprofloxacin in bacterial exacerbation of chronic bronchitis. Journal of Chemotherapy 1995; 7(5): 432–41
   Google Scholar
• Allegra L, Konietzko N, Leophonte P et al. Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease. Journal of Antimicrobial Chemotherapy 1996; 37(suppl A): 93–104
   PubMedGoogle Scholar
• Biebuyck XA. Comparison of azithromycin and co-amoxiclav in the treatment of acute tracheobronchitis and acute infectious exacerbations of chronic bronchitis in adults. J Int Med Res 1996; 24(5): 407–18
   Google Scholar
• Gris P. Once daily, 3-day azithromycin versus a three-times daily, 10-day course of co-amoxiclav in the treatment of adults with lower respiratory tract infections: results of a randomised, double-blind comparative study. Journal of Antimicrobial Chemotherapy 1996; 37 (suppl C): 93–101
   Google Scholar
• Perez-Gonzalvo ME, Mosquera-Pestana JA, Ramos D et al. Oflaxacin versus trimethoprim-sulfamethoxazole in the treatment of patients with acute exacerbation of chronic bronchitis. Clinical Therapeutics 1996; 18(3): 440–7
   Google Scholar
• Wool C, Cerutti R, Garbagna N et al. A cost-effective study of four different antibiotics in the treatment of acute exacerbations of chronic obstructive pulmonary disease. British Journal of Medical Economics 1996; 10: 159–68.
   Google Scholar
• DeAbate CA, Russell M, McElvaine P et al. Safety and efficacy of oral levofloxacin versus cefuroxime axetil in acute bacterial exacerbation of chronic bronchitis. Respiratory Care 1997; 42(2): 206–13
   Google Scholar
• Van Royen P, Betz W, Heyrman J et al. Dirithromycin versus amoxiclav in the treatment of acute exacerbations of chronic bronchitis. J Int Med Res 1997; 25(1): 33–40
   Web of Science ®Google Scholar
• Gruneberg RN, Felmingham D, and the Alexander Project Group. Results of the Alexander Project: a continuing, multicenter study of antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens. Diagnostic Microbiology and Infectious Disease 1996; 25(4): 169–81
   Web of Science ®Google Scholar
• Nightingale CH, Quintiliani R. Cost of oral antibiotic therapy. Pharmacotherapy 1997; 17(2): 302–7
   Web of Science ®Google Scholar
• Davey P, Parker S. Cost effectiveness of once-daily oral antimicrobial therapy. Journal of Clinical Pharmacology 1992; 32: 706–10
   PubMed Web of Science ®Google Scholar
• Chodosh S, Schreurs AJM, Shan M et al. The efficacy of oral ciprofloxacin versus clarithromycin for the treatment of acute bacterial exacerbations of chronic bronchitis (ABECB). Presented at the 34th Annual Meeting of the Infectious Diseases Society of America (IDSA), September 1996, New Orleans, Louisiana, USA
   Google Scholar
• Grossman R, Eastwood C, Lampron N. A 1-year community-based health economic study of ciprofloxin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 1998; 113(1): 131–41
   Web of Science ®Google Scholar
• Geddes AM. Grepafloxacin - focus on respiratory infections. Journal of Antimicrobial Chemotherapy 1997; 40 (suppl A): 1–4
   Google Scholar